PAR-22-089 - Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders NOT-NS-22-010 NINDS Oct 1, 2021 Jan 8, 2025 R61/R33, U01, U44

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI) in Migraine and Headache Research NOT-NS-22-051 NINDS Dec 27, 2021 May 8, 2022 U01, K01, UG3/UH3, K22, K99/R00, K02, K08, R01, F30, K23, F32, R21, F31, R61/R33
Notice of Special Interest (NOSI) in NINDS mission relevant Pain Research NOT-NS-22-050 NINDS Dec 27, 2021 May 8, 2022 K01, UG3/UH3, K99/R00, K22, K08, R01, K02, F30, K23, R21, F32, F31, U01, U24, R61/R33


Technical Issues: E-mail OER Webmaster